Like viruses in general, the corona virus can mutate and form a new format.
REPUBLIKA.CO.ID, JAKARTA – The new variant of Covid-19 has spread to various parts of the world, and many researchers are concerned that the available vaccines are not effective in controlling virus mutations. Therefore, researchers are currently developing a new vaccine to fight a new variant of Covid-19.
Like viruses in general, the corona virus can mutate and form a new format. Several variants of the virus, such as the British, South African and Brazilian variants, were identified as highly contagious and spreading.
University of Nottingham virologist, Professor Jonathan Ball, for example, sees the urgency of making a new vaccine.
“There is no indication that any of the emerging virus variants caused more severe disease than the original virus. However, there is evidence that some of these new variants may infect and spread more rapidly in populations with partial immunity, following natural infection or vaccination. “Ball said as quoted by Times Now News on Monday (22/2).
Vaccine development is reported to have reached its final stage, and production of a new vaccine has begun. The researchers also hope vaccine clinical trials new can also begin soon.
Another approach that is being explored by researchers is to insert extra doses of antibodies in the nose and throat. Researchers at the University of Bristol are conducting research on the subject.
To achieve this, the researchers measured the levels of antibodies in the mucosal secretions of people who had received different vaccines against the disease.
It is known, the new corona virus infection has claimed more than 2.47 million lives globally, and so far more than 112 million people have been infected. Vaccination against the virus has started in many parts of the world, including Indonesia.
– .
